Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2066 in Peripheral Neuropathic Pain
NCT00939094Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD-2066 in Peripheral neuropathic pain, sponsored by AstraZeneca. Started Aug 2009; status: terminated.
02
Drugs
AZD-2066
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT00939094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939094.